Figure 2From: Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer Levels of pSrc, Src, pFAK, and FAK in liver metastases treated with various chemotherapeutic regimens. Patients exposed to oxaliplatin demonstrated higher levels of pFAK expression when compared to patients exposed to a regimen containing irinotecan or 5-FU alone (cohort 1, N = 120).Back to article page